Yooper
Up. Identified. Lase. Fire. On the way.
Here's a blog I follow (for second career reasons). It's not a "guy on the street" view it's from someone who works in this field/adjacent to this field.
About halfway in:
In other words, this is really complicated. Sometimes it's better to go slow and steady than rush to judgment. This is a case of "just don't do something, stand there" for a bit.
--- End of line (MCP)
AAAS
blogs.sciencemag.org
About halfway in:
emphasis mineNow to vaccines. That list I’ve been referring to has a long string of people working in this area, and that’s a good thing, because a vaccine is probably the best long-term solution. A safe and effective vaccine, let me amend that, while noting that proving both of those is what makes vaccine development the field it is. You have the antibody-enhancement problem mentioned above, you have the potential for a pathogen to mutate its way out of efficacy, and you always have the risk of immunological side effects. Readers my age and older will recall the 1976 “swine flu” debacle, in which a huge campaign was launched to vaccinate the public against an epidemic that never actually materialized, while also setting off hundreds of well-publicized cases of Guillain-Barré syndrome. That is a well-known immune disorder that usually occurs after a mild viral infection, where the nervous system’s myelin sheaths come under attack. It generally resolves, but not always, and can land patients in intensive care. The swine flu vaccine (a live-attenuate-virus preparation) is the largest vaccine-driven GBS incident that I’m aware of, and we do not want to repeat that. Vaccines by definition are being given to large numbers of healthy people – it’s vital that you do not cause more trouble than you’re trying to prevent.
In other words, this is really complicated. Sometimes it's better to go slow and steady than rush to judgment. This is a case of "just don't do something, stand there" for a bit.
--- End of line (MCP)